Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

SHANMUGA HOSPITAL LTD.

NSE : NABSE : 544365ISIN CODE : INE0TD301017Industry : Hospital & Healthcare ServicesHouse : Private

BSE51.30-2.7 (-5 %)

PREV CLOSE ( ) 54.00

OPEN PRICE ( ) 54.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 122000

TODAY'S LOW / HIGH ( )51.30 54.00

52 WK LOW / HIGH ( ) 51.354

NSE

This Company is not listed in NSE

Select year

Particulars

Mar 2024

Mar 2023

Mar 2022

Operational & Financial Ratios

Earnings Per Share (Rs)

5.37

595.28

839.78

CEPS(Rs)

6.70

5.50

0.70

DPS(Rs)

0.00

Book NAV/Share(Rs)

17.49

1477.76

882.49

Tax Rate(%)

25.21

27.62

25.06

Margin Ratios

Core EBITDA Margin(%)

19.97

18.53

21.85

EBIT Margin(%)

17.76

17.44

21.74

Pre Tax Margin(%)

16.35

16.72

21.66

PAT Margin (%)

12.23

12.10

16.23

Cash Profit Margin (%)

15.26

13.58

16.55

Performance Ratios

ROA(%)

18.47

28.27

63.10

ROE(%)

36.34

50.44

95.16

ROCE(%)

33.50

51.71

127.45

Asset Turnover(x)

1.51

2.34

3.89

Sales/Fixed Asset(x)

3.01

6.00

17.09

Working Capital/Sales(x)

63.97

6.60

8.58

Efficiency Ratios

Fixed Capital/Sales(x)

0.33

0.17

0.06

Receivable days

54.37

49.04

41.57

Inventory Days

14.96

11.44

7.83

Payable days

70.30

26.86

18.06

Valuation Parameters

PER(x)

0.00

PCE(x)

0.00

Price/Book(x)

0.00

Yield(%)

EV/Net Sales(x)

0.39

0.11

-0.03

EV/Core EBITDA(x)

1.87

0.61

-0.12

EV/EBIT(x)

2.19

0.66

-0.13

EV/CE(x)

0.64

0.23

-0.16

M Cap / Sales

0.00

Growth Ratio

Net Sales Growth(%)

9.39

-4.92

0.00

Core EBITDA Growth(%)

20.26

-18.51

0.00

EBIT Growth(%)

11.41

-23.76

0.00

PAT Growth(%)

10.48

-29.11

0.00

EPS Growth(%)

-99.10

-29.11

0.00

Financial Stability Ratios

Total Debt/Equity(x)

0.53

0.65

0.00

Current Ratio(x)

1.05

1.85

2.37

Quick Ratio(x)

0.90

1.62

2.12

Interest Cover(x)

12.57

24.47

273.49

Total Debt/Mcap(x)